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I. Materials and Methods 
 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.  Pd(PPh3)4 was 
prepared using known methods.  Thin layer chromatography (TLC), both preparatory 
and analytical, was visualized by UV fluorescence quenching, p-anisaldehyde, I2, or 
KMnO4 staining.  Analytical super critical fluid chromatography (SFC) was 
performed using an SFC and AD-H column.  Preparatory SFC was performed with a 
SFC and a prep AD-H column (21 x 250 mm, 5mic part#19445).  Silica gel (particle 
size 0.032-0.063 mm) was used for flash chromatography.  1H NMR and 13C NMR 
spectra were recorded at 300 MHz or 500 MHz.  1H NMR spectra are reported 
relative to CDCl3 (7.26 ppm).  Data for 1H NMR spectra are reported as follows: 
chemical shift (ppm), multiplicity, coupling constant (Hz), integration.  Multiplicities 
are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, sept. = septet, 
m = multiplet, bs = broad singlet.  13C NMR spectra are reported relative to CDCl3 
(77.16 ppm).  FTIR spectra are reported in frequency of absorption (cm-1).  HRMS 
were acquired using a TOF with a multimode source in electrospray ionization (ESI), 
atmospheric pressure chemical ionization (APCI), or multimode-ESI/APCI. 
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Yields of methyl ester 30[1] and consumption of vinyl iodide 28[2] were quantified 
using the calibration curves (Figure SI-1A and B), which graph the area ratio of GC 
peaks as a function of the molar ratio of either the methyl ester 30 and the tridecane 
internal standard or substrate 28 and the tridecane internal standard.  This data was 




Figure SI-1.  (a) Calibration curve used to determine cross-coupling yields comparing methyl 
ester 30 and tridecane internal standard.  (b) Calibration curve used to determine cross-




Table SI-1.  (a) The molar ratio of product 30 and tridecane with the associated peak area 
ratio obtained from GC analysis.  (b) The molar ratio of substrate 28 and tridecane with the 





































Curve comparing product (30)


















Curve comparing substrate (28)







































III. Comparison of Spectral Data for Synthetic and Reported Basiliolide C (8), 
































Assignment Synthetic 8 (ppm) Multiplicity, J (Hz)
C2 6.05 6.06 dd, 6.4, 1.1
C3 3.29 3.29 d, 6.4
C4 — — —
C5 1.29 dd, 12.9, 4.6
C6 1.75 1.76 dddd, 13.8, 13.0, 12.9, 2.8
1.64–1.50 1.54 dddd, 13.8, 4.6, 3.9, 2.8
C7 1.93 1.94 ddd, 13.7, 3.9, 2.8
1.41 1.42 ddd, 13.7, 13.0, 2.8
1.32–1.24
C1 — ——
C9 3.14 3.15 s
C10 — — —
C11 7.00 7.00 dd, 17.7, 11.1
C12 5.17 dd, 11.0, 1.0
5.06 5.06 dd, 17.7, 1.0
C13 1.23 1.24 s
C14 1.12 1.12 s
C15 3.73 3.74 d, 10.8
5.16
C8 — ——
Multiplicity, J (Hz)Natural 8 (ppm)
C16 — — —
C17 5.00 5.01 d, 1.1
C18 — — —
C19 — — —
C20 — — —
C21 2.08 2.09 s
3.73 3.74 sOMe






















































































































Assignment Synthetic 4 (ppm) Multiplicity, J (Hz)
C2 6.07 6.08 dd, 6.5, 1.1
C3 3.06 3.07 d, 6.5
C4 — — —
C5 1.30 dd, 11.5, 6.5
C6 1.71–1.63 1.70–1.60 m
1.71–1.63 1.70–1.60 m




C9 3.23 3.24 s
C10 — — —
C11 5.00 5.01 d, 1.1
C12 — —
C13 — —
C14 0.97 0.98 s
C15 1.08 1.09 s
—
C8 — ——
Multiplicity, J (Hz)Natural 4 (ppm)
C16 5.80 5.81 dd, 17.4, 10.8
C17 5.03 5.05 br d, 10.7
C18 1.60 1.61 s















































































































Assignment Synthetic 5 (ppm) Multiplicity, J (Hz)
C2 6.09 6.08 dd, 6.5, 1.2
C3 3.06 3.04 d, 6.6
C4 — — —
C5 1.34 dd, 12.6, 5.3
C6 1.64 1.65–1.53 m
1.59–1.56 1.65–1.53 m
C7 1.39 1.39 ddd, 13.0, 13.0, 3.3
1.91 1.89 ddd, 13.0, 3.3, 3.3
1.33
C1 — ——
C9 3.13 3.14 s
C10 — — —
C11 5.02 5.02 d, 1.1
C12 — —
C13 — — —
C14 0.97 0.96 s
C15 1.04 1.02 s
—
C8 — ——
Multiplicity, J (Hz)Natural 5 (ppm)
C16 7.00 6.98 dd, 17.8, 11.2
C17 5.15 5.11 dd, 11.1, 1.1
C18 1.22 1.21 s















































































IV. Bioactivity of Synthetic Transtaganolide C (4) 
 
Appendino, Muñoz and coworkers assayed naturally isolated transtaganolide C (4) for 
its effect on calcium mobilization as well as cell viability following exposure to the 
natural product 4.[5]  To ensure the data obtained was not the result of  trace 
thapsigargin (1) contamination in the isolation sample, we sent synthetic 
transtaganolide C (4) to be tested as a control.  Both calcium mobilization (Figure SI-
2)[6] and cell viability (Figure SI-3)[6] assays were consistent with those observed with 




Figure SI-2.  The effect of synthetic transtaganolide C (4) or naturally isolated thapsigargin 






Figure SI-3.  Percentage of cells still viable after 24 hours of exposure to either synthetic 
transtaganolide C (4) or thapsigargin (1).[6] 
 
 
General procedure for calcium mobilization.  Jurkat cells were incubated for 1 h at 
37 ºC in Tyrode’s salt solution (137 mM  NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1.0 mM 
MgCl2, 0.4 mM NaH2PO4, 12.0 mM NaHCO3, 5.6 mM  D-glucose) containing 5 µM 
Indo1-AM (Invitrogen) for 30 minutes at 37 °C in the dark.  Cells were then 
harvested, washed three times with buffer to remove extracellular Indo-1 dye,  
readjusted to 106 cells/mL in the appropriate buffer and analyzed in a 
spectrofluorimeter operated in the ratio mode (Hitachi F-2500 model, Hitachi Ltd.) 



























thapsigargin (1) ionomycin (10 µM)
transtaganolide C (4) 1µM
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transtaganolide C (4) thapsigargin (1)
 S12 
jacketed device.  After five minutes for accommodation to equilibrate temperatures, 
samples were excited at 338 nm and emission was collected at 405 and 485 nm, 
corresponding to the fluorescence emitted by Ca2+-bound and free Indo-1, 
respectively.  [Ca2+]i was calculated using the ratio values between bound- and free-
Indo-1 fluorescence, and assuming an Indo-1 Kd for Ca2+ of 0.23 µM.  Maximum and 
minimum ratio values for calculations were determined by the addition at the end of 
the measurements of 10 µM ionomycin.  [Ca2+]i changes are presented as changes in 
the ratio of bound-to-free calcium (340 nm/380 nm).[6] 
 
General procedure for cell viability.  For cytotoxicity analysis, Jurkat cells were 
seeded in 96-well plates in complete medium and treated with increasing doses of 
transtaganolide C (4) or thapsigargin (1) at the indicated concentrations (µM) for 24 
hours.  Samples were then diluted with 300 µL of PBS and incubated 1 minute at 23 
°C in the presence of propidium iodine (10 µg/ml).  After incubation, cells were 
immediately analyzed by flow cytometry.  The results are represented as the 
percentage of viability considering 100% viability for the untreated cells.[6] 
_____________________________________________________________________ 
[1] Methyl ester 30 was synthesized for GC studies using known methods: 
Kapferer, T.; Brückner, R. Eur. J. Org. Chem. 2006, 2119–2133. 
[2] Iodo-cyclohexene (28) synthesized for GC studies using known methods: 
Kropp, P. J.; McNeely, S. A.; Davis, R. D. J. Am. Chem. Soc. 1983, 105, 6907–
6915. 
[3] Appendino, G.; Prosperini, S.; Valdivia, C.; Ballero, M.; Colombano, G.; 
Billington, R. A.; Genazzani, A. A.; Sterner, O. J. Nat. Prod. 2005, 68, 1213–
1217. 
[4] Saouf, A.; Guerra, F. M.; Rubal, J. J.; Moereno-Dorado, F. J.; Akssira, M.; 
Mellouki, F.; López, M.; Pujadas, A. J.; Jorge, Z. D.; Massanet, G. M. Org Lett. 
2005, 7, 881–884. 
[5] Navarrete, C.; Sancho, R.; Caballero, F. J.; Pollastro, F.; Fiebich, B. L.; Sterner, 
O.; Appendino, G.; Muñoz, E. J. Pharmacol. Exp. Ther. 2006, 319, 422–430. 
[6] Muñoz, E. Departamento de Biología Celular, Fisiología e Inmunología, 
Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain.  Personal 






















































































































Figure SI-4C 13C NMR (75 MHz, CDCl3) of compound 17. 
 













































































































Figure SI-5C 13C NMR (75 MHz, CDCl3) of compound 18. 
 
















































































































Figure SI-6C 13C NMR (75 MHz, CDCl3) of compound SI-1. 
 









































































































Figure SI-7C 13C NMR (75 MHz, CDCl3) of compound 19. 
 


















































































































Figure SI-8C 13C NMR (75 MHz, CDCl3) of compound 14. 
 




























































































































Figure SI-9C 13C NMR (75 MHz, CDCl3) of compounds 21 and 22. 
 

































































































































Figure SI-10C 13C NMR (75 MHz, CDCl3) of compounds 23 and 24. 
 























































































































Figure SI-11C 13C NMR (125 MHz, CDCl3) of basiliolide C (8). 
 

























































































































Figure SI-12C 13C NMR (125 MHz, CDCl3) of epi-basiliolide C (9). 
 
















































































































Figure SI-13C 13C NMR (125 MHz, CDCl3) of compound 11. 
 




















































































































Figure SI-14C 13C NMR (125 MHz, CDCl3) of basiliopyrone (10). 
 






















































































































Figure SI-15C 13C NMR (125 MHz, CDCl3) of transtaganolide C (4). 
 
























































































































Figure SI-16C 13C NMR (125 MHz, CDCl3) of transtaganolide D (5). 
 
Figure SI-16B infrared spectrum (Thin Film, NaCl) of transtaganolide D (5). 
 
